The purpose of the public workshop is to have scientific discussions on methods to evaluate the Opioid Analgesics Risk Evaluation and Mitigation Strategy (OA REMS).

The workshop has three main objectives:

  • The first objective is to discuss what specific, measurable outcomes might demonstrate that training based on the Opioid Analgesics REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients With Pain (FDA Blueprint) is effective in educating prescribers and other health care providers (including pharmacists and nurses) involved in the treatment and monitoring of patients in pain about recommended pain